Fatty liver, hypertension, and the metabolic syndrome
Open Access
- 1 July 2004
- Vol. 53 (7), 923-924
- https://doi.org/10.1136/gut.2003.037309
Abstract
The prevalence of fatty liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.Keywords
This publication has 30 references indexed in Scilit:
- Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistanceGut, 2004
- High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis CHepatology, 2003
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Current best treatment for non-alcoholic fatty liver diseaseExpert Opinion on Pharmacotherapy, 2003
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology, 2003
- Insulin sensitisation in the treatment of Type 2 diabetesExpert Opinion on Investigational Drugs, 2003
- Nonalcoholic fatty liver disease: An agenda for clinical researchHepatology, 2002
- Clustering of silent cardiovascular risk factors in apparently healthy HispanicsJournal of Human Hypertension, 2002
- Pharmacological management of high triglycerides and low high-density lipoproetin cholesterolCurrent Opinion in Pharmacology, 2001
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999